Taiwan has antimalarial drug seen as possible COVID-19 treatment: CECC

Quinoline antimalarial drugs, which have recently been discussed as a possible treatment for the COVID-19 coronavirus, are produced in Taiwan and could be made available if testing proves them to be effective, the Central Epidemic Command Center (CECC) said Thursday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)